The first subcutaneously delivered long-acting reversible contraceptive (LARC) has been launched in the UK.
Medroxyprogesterone acetate (Sayana Press) is administered under the skin into the thigh or abdomen every 13 weeks using a prefilled Uniject injection.
The active ingredient, medroxyprogesterone acetate, is similar to the natural hormone progesterone produced in the ovaries.
The new Uniject device makes it “convenient and straightforward” for a doctor or nurse to administer, according to its manufacturer Pfizer.
Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.